Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for ...
EBD™ bispecific antibodies targeting both AβOs and hTfR showed improved brain penetration compared to the native anti-AβO antibodies, which may enable administration with a low-volume delivery device ...
Engineering teams face steep challenges when it comes to staying on schedule, and keeping to those schedules can have an impact on the entire organization. Acumen, an Israeli engineering operations ...
NEWTON, Mass., March 27, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic ...
Global nonprofit impact investor Acumen has launched a Valentine’s Day campaign urging chocolate lovers to “Make a #Cocoamitment” by choosing chocolate brands that support fair wages for cocoa farmers ...
Today’s businesses need to adapt faster than ever, global competition is fierce and, according to a recent article in the New York Times, retirement rates are accelerating. The next generation of ...
According to Consultancy.uk, Korn Ferry reports that CHROs may be lacking in a specific area of human resource skills as they're seeking new positions or promotions. In fact, business acumen is the ...
SAN MATEO, Calif.--(BUSINESS WIRE)--Accorded, Inc., a leader in healthcare actuarial intelligence, unveils its latest offering: Accorded Acumen. Acumen is an actuarial data transformation platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results